TTAB Oppositions 91281267
USPTO Oppositions proceeding 91281267, filed 2022-10-19. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91281267 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2022-10-19 |
| Last Activity | 2023-02-01 |
| Days Active | 1305 |
Parties
- Genesis Drug, Discovery & Development, LLC — Defendant
- Helix OpCo, LLC — Plaintiff
Plaintiff Marks
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
- HELIX — Helix OpCo, LLC
Defendant Marks
- HELIX CONNECT — Genesis Drug, Discovery & Development, LLC
- HELIX CONNECT — Genesis Drug, Discovery & Development, LLC
Recent Documents
- 2023-02-01: TERMINATED — Status
- 2023-02-01: BD DECISION: OPP DISMISSED W/ PREJ — Decisions
- 2023-02-01: W/DRAW OF APPLICATION — Withdrawals
- 2023-01-24: SUSPENDED — Status
- 2023-01-24: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2022-11-28: EXTENSION OF TIME GRANTED — Extensions
- 2022-11-28: D MOT FOR EXT W/ CONSENT — Motions
- 2022-11-01: SUSPENDED — Status
- 2022-11-01: D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS — Motions
- 2022-10-19: INSTITUTED — Status
- 2022-10-19: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2022-10-19: FILED AND FEE — Fees